Skip to main content

Table 1 Characteristics of subjects with PDAC and controls

From: Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma

 

Tissue samples

Serum samples in the discovery group

Serum samples (post-operative)

Serum samples

Serum samples in the validation group

Variable

Cases (n= 64)

Healthy controls (n=500)

Benign disease (n=115)

Chronic pancreatitis (n=50)

PDAC cases (n=807)

Curative PDAC cases (n= 102)

Non-curative PDAC cases (n= 31)

PDAC cases (n= 35)

Healthy controls (n= 50)

Stage 1 PDAC cases (n= 50)

Gender (n)

          

Male

35

287

63

27

438

57

17

19

28

31

Female

29

213

52

23

369

45

14

16

22

19

Age (years)

          

≤45

23

102

26

17

111

30

4

8

15

16

46-55

25

153

34

14

215

38

4

13

12

14

56-65

14

121

29

12

272

23

9

8

12

13

>65

2

124

18

7

209

11

14

6

11

7

Stage (n)

          

I

25

   

45

31

 

4

 

50

II

39

   

127

68

2

26

  

III

    

337

3

29

   

IV

    

298

     
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us